A jury trial over the opioid crisis begins in Rhode Island this week with Morgan, Lewis & Bockius against Motley Rice, two law firms that previously faced off in California.
Rhode Island Attorney General Peter Neronha is alleging that generic pharmaceutical manufacturer Teva Pharmaceutical Industries Ltd. fraudulently misrepresented the risks of its opiate pharmaceuticals, which it promoted for off-label uses, creating a public nuisance. Teva, fending off similar public nuisance claims last year, won a bench trial in California with a Morgan Lewis team led by Pittsburgh partner Wendy Feinstein. Motley Rice’s Fidelma Fitzpatrick, who represented three large California counties and Oakland in that trial, is spearheading the team for Rhode Island.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
